ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

INMB INmune Bio Inc

11,29
0,45 (4,15%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
INmune Bio Inc INMB NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,45 4,15% 11,29 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
10,83 10,83 11,73 11,29 10,84
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/04/202410:00GLOBEINmune Bio Inc. Announces $9.7 Million Registered Direct..
23/04/202409:00GLOBEINmune Bio Inc. Announces 24-Month Stability Validation of..
22/04/202409:00GLOBEINmune Bio Inc. Raises Approximately $4.8 Million in Gross..
08/04/202409:00GLOBEINmune Bio Inc. Presents Data on INB03’s Role as an Immune..
28/03/202417:01GLOBEINmune Bio Inc. Announces Year End 2023 Results and Provides..
26/03/202417:01GLOBEINmune Bio Inc. to Report Fourth Quarter 2023 Financial..
13/03/202409:00GLOBEINmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives..
05/03/202410:00GLOBEINmune Bio Reports Significant EEG Improvement in..
12/02/202411:00GLOBEINmune Bio to Participate in the Oppenheimer 34th Annual..
06/02/202411:00GLOBEINmune Bio to Participate in Baird’s Biotech Discovery..
30/01/202410:00GLOBEINmune Bio Announces FDA Removal of Clinical Hold for..
16/01/202410:30GLOBEELEVAI Labs, Inc. Acquires Worldwide License Agreement for..
02/01/202410:00GLOBEINmune Bio Announces First Patient Dosed in a Phase 1/2..
18/12/202318:01GLOBEINmune Bio Provides Update Regarding Global Alzheimer’s..
29/11/202310:00GLOBEINmune Bio Inc. Demonstrates that INB03 Enhances the Uptake..
27/11/202310:00GLOBEINmune Bio Receives EMA’s Authorization in France and Spain..
15/11/202311:00GLOBEINmune Bio Inc. Announces Expansion of Phase II Clinical..
01/11/202317:10GLOBEINmune Bio Inc. Announces Third Quarter 2023 Results and..
31/10/202309:00GLOBEINmune Bio Inc. Patent Claims Covering INB16 Cell Line and..
30/10/202310:07GLOBEINmune Bio Inc. Presents Preclinical Data at SITC 2023..
17/10/202309:00GLOBEINmune Bio Inc. Presents New Biomarker and Feasibility Data..
16/10/202310:00GLOBEINmune Bio Inc. to Report Third Quarter 2023 Financial..
07/09/202310:00GLOBEINmune Bio Inc. to Present at Baird Global Healthcare..
05/09/202309:00GLOBEINmune Bio Inc. Announces Approval of Clinical Trial..
07/08/202317:00GLOBEINmune Bio Inc. Announces Second Quarter 2023 Results and..
01/08/202309:00GLOBEINmune Bio Inc. to Present at the BTIG Virtual ..
31/07/202309:00GLOBEINmune Bio, Inc. to Report Second Quarter 2023 Financial..
12/07/202309:00GLOBEINmune Bio Inc. to Deliver Keynote Talk at 5th World Aging..
11/07/202309:00GLOBEINmune Bio Inc. Announces Novel MRI Biomarker Data..
10/07/202317:00GLOBEINmune Bio Inc. Announces Data Presented at the 16th..
24/05/202310:00GLOBEINmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell,..
08/05/202309:00GLOBEINmune Bio, Inc. Announces FDA Clearance of IND Application..
03/05/202317:10GLOBEINmune Bio Inc. Announces First Quarter 2023 Results and..

Seu Histórico Recente

Delayed Upgrade Clock